Newsroom

Recent Press Releases

January 30, 2024
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
December 21, 2023
U.S. FDA Approves Label Update for Kite’s Yescarta® CAR T-Cell Therapy to Include Overall Survival Data

Recent Company Statements

October 2, 2023
Kite Appoints Priti Hegde as Global Head of Research

Explore More

Media Inquiries

Gilead Newsroom